fluoxetine has been researched along with Death, Sudden, Cardiac in 5 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Death, Sudden, Cardiac: Unexpected rapid natural death due to cardiovascular collapse within one hour of initial symptoms. It is usually caused by the worsening of existing heart diseases. The sudden onset of symptoms, such as CHEST PAIN and CARDIAC ARRHYTHMIAS, particularly VENTRICULAR TACHYCARDIA, can lead to the loss of consciousness and cardiac arrest followed by biological death. (from Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 7th ed., 2005)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pemoline was associated with a significant decrease in the high frequency (HF) power (0." | 2.71 | Effect of fluoxetine, pemoline and placebo on heart period and QT variability in normal humans. ( Balon, R; Doll, RG; Jayaraman, A; Pohl, R; Yeragani, V, 2003) |
| "Nonsudden cardiac death was treated as a competing event." | 1.51 | Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis. ( Assimon, MM; Brookhart, MA; Flythe, JE, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Assimon, MM | 2 |
| Pun, PH | 1 |
| Al-Khatib, SM | 1 |
| Brookhart, MA | 2 |
| Gaynes, BN | 1 |
| Winkelmayer, WC | 1 |
| Flythe, JE | 2 |
| Faingold, CL | 1 |
| Tupal, S | 1 |
| Randall, M | 1 |
| Pohl, R | 1 |
| Balon, R | 1 |
| Jayaraman, A | 1 |
| Doll, RG | 1 |
| Yeragani, V | 1 |
| Rouleau, F | 1 |
| Asfar, P | 1 |
| Boulet, S | 1 |
| Dube, L | 1 |
| Dupuis, JM | 1 |
| Alquier, P | 1 |
| Victor, J | 1 |
1 trial available for fluoxetine and Death, Sudden, Cardiac
| Article | Year |
|---|---|
Effect of fluoxetine, pemoline and placebo on heart period and QT variability in normal humans.
Topics: Adult; Anxiety Disorders; Cardiac Output; Central Nervous System Stimulants; Death, Sudden, Cardiac; | 2003 |
4 other studies available for fluoxetine and Death, Sudden, Cardiac
| Article | Year |
|---|---|
The modifying effect of the serum-to-dialysate potassium gradient on the cardiovascular safety of SSRIs in the hemodialysis population: a pharmacoepidemiologic study.
Topics: Case-Control Studies; Citalopram; Cohort Studies; Death, Sudden, Cardiac; Dialysis Solutions; Fluoxe | 2022 |
Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis.
Topics: Age Factors; Aged; Aged, 80 and over; Cardiac Conduction System Disease; Citalopram; Death, Sudden, | 2019 |
Prevention of seizure-induced sudden death in a chronic SUDEP model by semichronic administration of a selective serotonin reuptake inhibitor.
Topics: Acoustic Stimulation; Animals; Chi-Square Distribution; Death, Sudden; Death, Sudden, Cardiac; Disea | 2011 |
Transient ST segment elevation in right precordial leads induced by psychotropic drugs: relationship to the Brugada syndrome.
Topics: Adult; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; An | 2001 |